| Term 
 
        | Beta adrenergic receptors |  | Definition 
 
        | In smooth muscle and cardiac muscle Gs Increase cAMP -> downstream phosphorylation -> promote calcium inflow and reuptake -> increased contraction, rate of relaxation, and pacemaker activity (positive inotropic and chronotropic effects) 
 |  | 
        |  | 
        
        | Term 
 
        | Alpha 2 adrenergic receptors |  | Definition 
 
        | Gi Decrease cAMP --> promote contraction Postsynaptic CNS adenoreceptors Platelets Adrenergic and cholinergic nerve terminals Some vascular smooth muscle Fat cells |  | 
        |  | 
        
        | Term 
 
        | Alpha 1 adrenergic receptors |  | Definition 
 
        | Gq Increase Ca --> contraction |  | 
        |  | 
        
        | Term 
 
        | Clinical Uses for Epineprhine |  | Definition 
 
        | Affects alpha 1, alpha 2, beta 1, and beta 2 Used for anaphylactic shock (alpha, beta) Acute asthma attacks (beta) Prolong action of local anesthetics (alpha) Topical hemostatic agent (alpha) Cardiac arrest (alpha) 
 Side effects, esp in hyperthyroid or patients on beta blockers: hypertension, arrhythmia, angina, necrosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Catecholamine alpha 1 = alpha 2, beta 1 >> beta 2 Uncommon use for pressor effects |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Catecholamine Beta 1 = beta 2 >>> alpha Uncommonly used for bronchodilation (Beta 2 agonists are a better pick) Used for heart stimulation in bradycardia or heart block |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Catecholamine Beta 1 > Beta 2 >>> alpha Positive iontropic effects Some chrontropic effects Used in acute congestive heart failure |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Catecholamine D1=D2 >> beta 1 >> alpha D1 response = vasodilation of renal, mesenteric, and coronary beds Dose dependent.  Small dose -> D1 response, larger alpha effect May cause vasoconstriction -> ischemia of peripheral tissues |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Norepinephrine Isoproterenol Dobutamine Dopamine   All produce tolerance over time Chronic use in heart failure may worsen outcome |  | 
        |  | 
        
        | Term 
 
        | Direct-acting Noncatecholamines |  | Definition 
 
        | Phenyleprhine Clonidine Albuterol Ritodrine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct-acting noncatecholamine Alpha 1 > alpha 2 >>> beta Vasoconstrictive effects Used to treat hypotension and shock Used as topical nasal decongestant Topical opthalmic treatment causes myadriasis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct acting noncatecholamine Alpha 2 > alpha 1 >>>> Beta Penetrates CNS Inhibits sympathetic output  Causes hypotension, bradycardia, sedation Used in hypertension, to diminish cravings in narcotic, alcohol, and nicotine withdrawal |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct acting noncatecholamine Beta 2 > beta 1 >>> alpha Used for bronchodilation in asthma, COPD Inhalant prep to minimize systemic effects Sometimes used to stop preterm labor by relaxing uterus (better drugs for this) |  | 
        |  | 
        
        | Term 
 
        | Indirect-acting Noncatecholamines |  | Definition 
 
        | Amphetamine Methylphenidate Cocaine Tyramine |  | 
        |  | 
        
        | Term 
 
        | Amphetamine Methylphenidate |  | Definition 
 
        | Indirect acting noncatecholamine Enters CNS to cause release of catecholamines (incl. DA) CNS effects: mood elevation, increased alertness, decreased appetite Peripheral effects: NE-like Used for narcolepsy, weight loss, ADD |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect acting noncatecholamine Causes vasoconstriction and local anesthesia   Abuse side effects = hypertensive response |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect acting noncatecholamine Found in food When MAO inhibitor present, promotes norepi release, causing NE-like hypertensive response |  | 
        |  | 
        
        | Term 
 
        | Mixed Direct and Indirect Noncatecholamines |  | Definition 
 
        | Ephedrine and pseudoephedrine Some CNS penetration -> mild stimulant Orally available Excreted unchanged Long duration of action Used in cold meds for nasal decongestion |  | 
        |  | 
        
        | Term 
 
        | Nonspecific alpha blcokers |  | Definition 
 
        | Block alpha 1 and alpha 2 Predominant effect = vasodilation Can cause reflex tachycardia by decreased alpha 2 feedback inhibition Increased cardiac output blunts hypotensive response Adverse effects: orthostatic hypotension, nasal stuffiness, tachycardia 
 Example: phenoxybenzamine, phenotlamine   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonspecific alpha blocker Requires bioactivation (lag in onset) Covalent Irreversible (24+ hour duration) Used to treat pheochromocytoma   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonspecific alpha blocker Competitive - short duration of action   Used for: Short term treatment of pheochromocytoma Iatrogenic alpha-agonist reversal Hypertensive crisis (from clonidine withdrawal, or tyramine + MAOI interaction) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Specific for alpha 1 receptor Decrease BP with less reflex stimulation of heart rate Decreases preload and afterload 
 Used to treat hypertension or promote urine flow  First dose causes orthostatic hypotension, then tolerance develops   Example: prazosin, terazosin, tamsulosin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha 1 blockers For treatment of hypertension and BPH   First dose produces orthostatic hypotension before tolerance kicks in |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha 1 blocker   Some selectivity for alpha 1A receptors Promotes urine flow in BPH with little effect on BP |  | 
        |  | 
        
        | Term 
 
        | Structure of beta blockers |  | Definition 
 
        | Structurally similar to catecholamines Ring + tail motif |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. Decrease heart rate and contractility.   Short term: decrease CO, increase PVR (Beta 2 block) Long term: Decrease myocardial O2 consumption 2. Decrease hypertension (no effect if normal) 3. Antagonism of bronchodilation via beta2s (bad for COPD, asthma) 4. Decrease aqueous humor production from ciliary epithelium 5. Blocks glucose metabolization (beta 2 antagonism of glycogenolysis) 6. Slow lipolysis -> increases VLDL, lowers HDL |  | 
        |  | 
        
        | Term 
 
        | Clinical uses of Beta Blockers |  | Definition 
 
        | Angina Hypertension Supraventricular arrhythmia Ventricular arrhythmia Myocardial infarction Hyperthyroidism/thyroid storm Migraine Heart failure |  | 
        |  | 
        
        | Term 
 
        | Side effects of Beta Blockers |  | Definition 
 
        | Heart failure Bradycardia COPD/asthma Angina, sudden death if in withdrawal Blunt recovery from hypoglycemia Adverse plasma lipoprotein profile CNS effects - sleep disturbance, depression |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart - increases force/rate of contractions Juxtaglomerular cells - stimulates renin release |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Found in most vascular smooth muscle Pupillary dilator muscle Pilomotor smooth muscle Prostate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Respiratory, uterine, vascular smooth muscle Skeletal muscle Liver |  | 
        |  |